ArticlePLoS pathogens2026
Biophysical and functional characterization of the Escherichia coli Dr fimbrial envelope reveals its importance for pathogenesis and lithogenesis.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uropathogenic Escherichia coli strains rely on specialized surface appendages to colonize the urinary tract, including Dr fimbriae, which are strongly associated with recurrent infection and long-term persistence. Although traditionally described as receptor-binding fibers, their broader contribution to bacterial surface architecture and physicochemical behavior has remained unclear. Here, combining quantitative proteomics, computational modeling, rheology, surface physicochemistry, and flow-based adhesion assays, we show that Dr fimbriae collectively form a dense, highly hydrated amphipathic envelope surrounding the bacterial cell. Rather than functioning as isolated filaments, they generate a dynamic supramolecular layer approximately 200-300 nm thick that markedly alters whole-cell properties. Mechanistic analyses performed in a simplified laboratory model were validated in the clinical UPEC strain IH11128, demonstrating that the principal physicochemical and adhesive properties of the Dr envelope are preserved despite phase-variable fimbrial expression. The Dr envelope strongly enhanced adhesion to abiotic surfaces, particularly hydrophilic glass, where Dr-positive bacteria resisted nanonewton-range capillary detachment forces, indicating stable multipoint anchoring. The envelope also promoted selective binding to calcium oxalate (CaOx), the principal mineral component of kidney stones, under urinary conditions. In the clinical isolate, CaOx binding occurred almost exclusively within the Dr-positive subpopulation and was largely abolished by anti-Dr antibodies, demonstrating that mineral recognition depends specifically on Dr fimbriae. Beyond adhesion, the fimbrial mesh functioned as a size-selective molecular filter. Dr-positive bacteria showed markedly reduced susceptibility to large bacteriophages, whereas infection by smaller phages and susceptibility to low-molecular-weight antibiotics remained unchanged, indicating steric exclusion of large biological particles without restricting diffusion of small solutes. Together, these findings establish the Dr envelope as a multifunctional supramolecular surface architecture that governs bacterial surface physicochemistry, promotes stable urinary tract colonization, mediates CaOx recognition, and expands the adaptive capabilities of UPEC within the urinary tract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.